Find therapies in clinical trials near you – page 36

Study on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome

Study on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Safety and tolerability of intrathecal S233107 in participants with spinocerebellar ataxia type 3: a Phase 1b/2a first‑in‑human randomized study

Safety and tolerability of intrathecal S233107 in participants with spinocerebellar ataxia type 3: a Phase 1b/2a first‑in‑human randomized study

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

Study of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer

Study of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer

Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

A study to evaluate how food affects the absorption of cytisinicline in healthy adult smokers

Pharmacokinetics of Nicorandil 40 mg Extended‑Release Capsules in Healthy Volunteers Under Fasting and Fed Conditions

Comparison of Bioavailability of Ruxolitinib Phosphate 20 mg Tablet vs Ruxolitinib 20 mg Tablet in Healthy Volunteers

Single‑dose Bioavailability of Gliclazide Modified‑Release Tablets in Healthy Volunteers (Type 2 Diabetes)

Single‑dose Bioavailability of Gliclazide Modified‑Release Tablets in Healthy Volunteers (Type 2 Diabetes)

A study to compare how the body absorbs empagliflozin tablets in healthy individuals.